MRCHF (H U Group Holdings) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MRCHF H U Group Holdings Inc MRCHF
63 GF Score
Price $20.90
GF Value $19.09
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is H U Group Holdings Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

MRCHF
63GF Score
H U Group Holdings Inc MRCHF
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is H U Group Holdings (MRCHF) Overvalued in 2026?

Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued. The current stock price of $20.90 is trading 9.5% above its estimated GF Value™ of $19.09. GuruFocus considers H U Group Holdings to be Fairly Valued.

Key valuation signals for MRCHF:

  • Dividends Received:
  • GF Value™: $19.09 vs. price of $20.90 (9.5% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the MRCHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H U Group Holdings Business Description

Other Exchanges 4544:Japan
Address Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
63GF Score

Get the complete analysis for MRCHF

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.90
Price
$19.09
GF Value